loading
前日終値:
$0.2964
開ける:
$0.2976
24時間の取引高:
114.62K
Relative Volume:
0.11
時価総額:
$13.37M
収益:
-
当期純損益:
$-37.75M
株価収益率:
-0.0912
EPS:
-3.25
ネットキャッシュフロー:
$-30.91M
1週間 パフォーマンス:
-2.46%
1か月 パフォーマンス:
-11.78%
6か月 パフォーマンス:
-85.59%
1年 パフォーマンス:
-90.47%
1日の値動き範囲:
Value
$0.292
$0.3005
1週間の範囲:
Value
$0.291
$0.32
52週間の値動き範囲:
Value
$0.224
$3.51

Cellectar Biosciences Inc Stock (CLRB) Company Profile

Name
名前
Cellectar Biosciences Inc
Name
セクター
Healthcare (1153)
Name
電話
(608) 441-8120
Name
住所
100 CAMPUS DRIVE, FLORHAM PARK, NJ
Name
職員
11
Name
Twitter
@CellectarBio
Name
次回の収益日
2025-03-05
Name
最新のSEC提出書
Name
CLRB's Discussions on Twitter

CLRB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CLRB
Cellectar Biosciences Inc
0.2965 13.37M 0 -37.75M -30.91M -3.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.66 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.82 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
634.11 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
258.70 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
248.15 24.70B 3.81B -644.79M -669.77M -6.24

Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-05 再開されました Ladenburg Thalmann Buy
2020-07-01 開始されました Oppenheimer Outperform
2020-01-21 再開されました ROTH Capital Buy
2019-09-13 開始されました ROTH Capital Buy
2016-12-21 開始されました Ladenburg Thalmann Buy

Cellectar Biosciences Inc (CLRB) 最新ニュース

pulisher
08:54 AM

Financial Metrics Unveiled: Cellectar Biosciences Inc (CLRB)’s Key Ratios in the Spotlight - DWinneX

08:54 AM
pulisher
Apr 27, 2025

Cellectar Biosciences (NASDAQ:CLRB) Earns Sell Rating from Analysts at StockNews.com - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 19, 2025

Cellectar Biosciences (NASDAQ:CLRB) Stock Price Passes Below 200-Day Moving Average – What’s Next? - Defense World

Apr 19, 2025
pulisher
Apr 19, 2025

StockNews.com Initiates Coverage on Cellectar Biosciences (NASDAQ:CLRB) - Defense World

Apr 19, 2025
pulisher
Apr 11, 2025

Cellectar Biosciences (NASDAQ:CLRB) Coverage Initiated by Analysts at StockNews.com - Defense World

Apr 11, 2025
pulisher
Apr 09, 2025

Sarepta Therapeutics (NASDAQ:SRPT) versus Cellectar Biosciences (NASDAQ:CLRB) Financial Analysis - Defense World

Apr 09, 2025
pulisher
Apr 03, 2025

Cellectar Biosciences (NASDAQ:CLRB) Coverage Initiated at StockNews.com - Defense World

Apr 03, 2025
pulisher
Mar 31, 2025

Financial Contrast: Cellectar Biosciences (NASDAQ:CLRB) versus Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Mar 31, 2025
pulisher
Mar 26, 2025

Cellectar Biosciences (NASDAQ:CLRB) Now Covered by StockNews.com - Defense World

Mar 26, 2025
pulisher
Mar 19, 2025

Cellectar Biosciences (CLRB) to Release Earnings on Wednesday - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 18, 2025
pulisher
Mar 18, 2025

StockNews.com Begins Coverage on Cellectar Biosciences (NASDAQ:CLRB) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Cellectar Biosciences Enhances CEO and COO Severance Benefits - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

What is Roth Capital’s Estimate for CLRB FY2029 Earnings? - Defense World

Mar 17, 2025
pulisher
Mar 14, 2025

Earnings call transcript: Cellectar Biosciences Q4 2024 sees restructuring amid losses - Investing.com Australia

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences Inc (CLRB) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ... - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences Inc (CLRB) Q4 2024 Earnings Call Highlight - GuruFocus

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences Faces Financial and Legal Turmoil Amidst Restated Earnings - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences Advances Cancer Drug Pipeline - TipRanks

Mar 14, 2025
pulisher
Mar 13, 2025

Cellectar Biosciences Earnings Call: Mixed Outlook Amid Successes and Challenges - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

CELLECTAR BIOSCIENCES Earnings Results: $CLRB Reports Quarterly Earnings | CLRB Stock News - Quiver Quantitative

Mar 13, 2025
pulisher
Mar 13, 2025

Cellectar's Breakthrough: 83.6% Response Rate Puts FDA Fast Track Within Reach - StockTitan

Mar 13, 2025
pulisher
Mar 13, 2025

Cellectar Biosciences Provides Update on FDA Regulatory Path for Iopofosine I 131 in Waldenström Macroglobulinemia and Advances Phase 1 Trials for New Radioconjugates - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Cellectar Biosciences COO acquires $8,400 in stock By Investing.com - Investing.com Canada

Mar 13, 2025
pulisher
Mar 12, 2025

Cellectar Biosciences COO acquires $8,400 in stock - Investing.com India

Mar 12, 2025
pulisher
Mar 11, 2025

Cellectar Biosciences to Present at the 37th Annual Roth Conference - Quantisnow

Mar 11, 2025
pulisher
Mar 11, 2025

Cellectar Biosciences Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Cellectar Biosciences, Inc. to Present at 37th Annual Roth Conference - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Cancer Treatment Breakthrough? Cellectar Biosciences Reveals Latest Progress at Major Investor Conference - StockTitan

Mar 11, 2025
pulisher
Mar 10, 2025

Before You Invest, Make Sure You Check This Cellectar Biosciences Inc (NASDAQ: CLRB) Analysis - stocksregister.com

Mar 10, 2025
pulisher
Mar 10, 2025

Cellectar Biosciences (NASDAQ:CLRB) Now Covered by Analysts at StockNews.com - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

Cellectar Biosciences (CLRB) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 08, 2025
pulisher
Mar 05, 2025

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025 - GlobeNewswire

Mar 05, 2025
pulisher
Mar 05, 2025

Cellectar Biosciences, Inc. to Report 2024 Financial Results and Corporate Update on March 13, 2025 - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

When Will Cellectar Biosciences Reveal Its 2024 Financial Performance? - StockTitan

Mar 05, 2025
pulisher
Feb 15, 2025

2 No-Brainer Stocks to Buy Now With $250 Before They Soar in 2025, According to Wall Street - AInvest

Feb 15, 2025
pulisher
Feb 10, 2025

CLRB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Feb 10, 2025
pulisher
Feb 10, 2025

Prepare Yourself for Liftoff: Cellectar Biosciences Inc (CLRB) - SETE News

Feb 10, 2025

Cellectar Biosciences Inc (CLRB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
大文字化:     |  ボリューム (24 時間):